Show simple item record

dc.contributor.authorLickley, Robin
dc.date.accessioned2018-06-29T15:52:13Z
dc.date.available2018-06-29T15:52:13Z
dc.date.issued2007-10
dc.identifierER393
dc.identifier.citationLickley, R. (2007) Pharmacological approaches are not indicated for the treatment of stuttering., Evidence based Communication Assessment and Intervention, vol. 1, , pp. 159-162,
dc.identifier.issn1748-9539
dc.identifier.urihttps://doi.org/10.1080/17489530701852295
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/393
dc.description.abstractThe article discusses a study aimed to determine the effectiveness of pharmacological stuttering therapies. The study was designed as a systematic review with trial quality assessment. Included studies involved pharmacological treatment of persistent developmental stuttering in any age group and where some clinical effect was intended beyond the setting of the study itself, whether or not measurements beyond the clinic were reported.
dc.format.extent159-162
dc.publisherPsychology Press
dc.relation.ispartofEvidence based Communication Assessment and Intervention
dc.titlePharmacological approaches are not indicated for the treatment of stuttering.
dc.typearticle
dcterms.accessRightsrestricted
dc.description.facultycasl
dc.description.referencetextAlm, P. A. (2004). Stuttering and the basal ganglia circuits: A critical review of possible relations. Journal of Communication Disorders, 37, 325-369. Bothe, A. K., Davidow, J. H., Bramlett, R. E., & Ingham, R. J. (2006). Stuttering treatment research 1970-2005: I. Systematic review incorporating trial quality assessment of behavioral, cognitive, and related approaches. American Journal of Speech Language Pathology, 15, 321-341. Centre for Evidence-Based Medicine. (2006). Levels of evidence and grades of recommendation. Retrieved September 10, 2007, from http://www.cebm.net/index.asp Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18. Lavid, N., Franklin, D., & Maguire, G. (1999). Management of child and adolescent stuttering with olanzapine: Three case reports. Annals of Clinical Psychiatry, 11, 233-236. Lickley, R. (2007). Some stuttering treatments are possibly effective for some people, but more rigorous trials are required. [Abstract]. Evidence-based Communication Assessment and Intervention, 1, in press. Abstract of Bothe, A.,K., Davidow, J. H., Bramlett, R. E., & Ingham (2006). American Journal of Speech Language Pathology, 15, 321-341. Maguire, G., Riley, G., Franklin, D., & Gottschalk, L. (2000). Risperidone for the treatment of stuttering. Journal of Clinical Psychopharmacology, 20, 479-482. Maguire, G., Riley, G., Franklin, D., Maguire, M., Nguyen, C., & Brojeni, P. (2004). Olanzapine in the treatment of developmental stuttering: A double-blind, placebo-controlled trial. Annals of Clinical Psychiatry, 16, 63-67. Riley, G., Maguire, G., Franklin, D., Ortiz, T., & Riley, J. (2001). Effects of olanzapine on stuttering in adults. Paper presented at the meeting of the American Speech-Language Hearing Association. USA: New Orleans.
dc.description.volume1
dc.identifier.doihttp://10.1080/17489530701852295
dc.description.ispublishedpub
dc.description.eprintid393
rioxxterms.typearticle
qmu.authorLickley, Robin
qmu.centreCASLen
dc.description.statuspub
dc.description.number4


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record